Weight loss drugs are proving to be super popular among many workers with job-based health insurance. But GLP-1 medications are busting their employers’ budgets, leading some firms to rethink ...

Monlunabant, a novel cannabinoid receptor 1 (CB1R) inverse agonist, led to significant weight loss compared with placebo in patients with obesity and metabolic syndrome over 16 weeks; however, ...

GLP-1s may shrink the scale, but they can also shrink your muscle, especially your heart. When you stop the meds, dangerous belly fat often comes back fast and harder than before. Dr. Sean O’Mara ...